AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International...

Related Keywords

United States , San Diego , California , Puerto Rico , American , America , Kate Meyer , Jessica Akopyan , Justin Claeys , Lymphopoietin Isoforms , Jay Bradner , World Most Innovative Companies , Emergency Department Visit In Patients , Youtube , Teneobio Inc , Chemocentryx Inc , International Conference , Drug Administration , Exchange Commission , Kyowa Kirin Co Ltd , Beigene Ltd , American Thoracic Society , Linkedin , Airways Of Human Asthmatics In Vivo , Amgen , Astrazeneca , Instagram , Fast Company , Findings From , Severe Asthma , Adults With Severe Active , Associated Vasculitis With Lung , Clinical Trials , Presentation Times , Very Severe Chronic Obstructive Pulmonary Disease , Uncontrolled Asthma , Nasal Polyps , Halla B , Open Label Study , Including Underrepresented Racial , Clinical Groups , Initial Baseline Demographics , Clinical Characteristics , Reducing Exacerbations Requiring Hospitalization , Emergency Department Visit , African American Patients , Pooled Analysis , Exercise Tolerance , Treatment Patterns , Exacerbation Rates , Biomarker Levels , After Initiation , Tezepelumab Treatment , Mucus Plugging , Spatially Associated , Reduced Air Trapping , Broad Population , Exacerbation Reductions , Healthy Volunteers , Medium High Dose Inhaled Corticosteroid , Long Acting Beta Agonist , Elevated Baseline Fractional Exhaled Nitric Oxide , Avacopan Versus Prednisone Taper , Associated Vasculitis , Lung Involvement , Post Hoc Analysis , Orphan Drug Designation , North America , Important Safety Information , Asthma Symptoms , Important Safety , Prescribing Information , Full Prescribing Information , Most Innovative , Best Large , Dow Jones Industrial , Nasdaq Stock Market , Horizon Therapeutics , Stromal Lymphopoietin Isoforms , Inflammatory Disorders , Human Asthmatics In Vivo , Potential Biomarker , Severe Refractory ,